1-3 of 3
Maija Hollmén
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Drug Profiling and CRISPR Screening Reveal Essential Pathways for NK Cell Cytotoxicity

Free
Jonas Bouhlal, Emmi Jokinen, Petra Nygren, Diogo Dias, Aleksandr Ianevski, Jay Klievink, Hanna Lähteenmäki, Essi Laajala, Hanna Duàn, Emmi Järvelä, Helka Göös, Matti Korhonen, Salomé Decombis, Konstantin Matjusinski, Mikko Myllymäki, Maija Hollmén, Khalid Saeed, Dean Anthony Lee, Tero Aittokallio, Sara Gandolfi, Olli Dufva, Satu Mustjoki
Journal: Blood
Blood (2024) 144 (Supplement 1): 913.
https://doi.org/10.1182/blood-2024-202448
Published: 2024
Journal Articles

Encouraging Efficacy of Bexmarilimab with Azacitidine in Relapsed or Refractory MDS in Bexmab Ph1/2 Study

Free
Mika Kontro, Anthony S. Stein, Marja Pyörälä, Johanna Rimpiläinen, Timo Siitonen, Jenna H Rannikko, Jesper Mickos, Rita Turpin, Milja Hakoniemi, Birge Berns, Sofia Aakko, Inka Pawlitzky, Maija Hollmén, Amer M. Zeidan, Naval Daver
Journal: Blood
Blood (2024) 144 (Supplement 1): 4265.
https://doi.org/10.1182/blood-2024-206804
Published: 2024
Journal Articles

Encouraging Efficacy Observed in Bexmab Study: A Phase 1/2 Study to Assess Safety and Efficacy of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies

Free
Mika Kontro, Anthony Selwyn Stein, Marja Pyörälä, Johanna Rimpiläinen, Timo Siitonen, Maija Hollmén, Marie-Louise Fjaellskog, Inka Pawlitzky, Amer M. Zeidan, Naval Daver
Journal: Blood
Blood (2023) 142 (Supplement 1): 2915.
https://doi.org/10.1182/blood-2023-174912
Published: 2023